Saini SS, Maurer M, Dytyatkovska Y, Springer E, et al. CT-P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, Active-Controlled, Phase 3 Study. Allergy 2025;80:2167-2177.
PMID: 39785096